Tenaya Therapeutics, Inc. (TNYA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 108.84M |
| Enterprise Value | 19.12M |
| P/E Ratio | -1.49 |
| PEG Ratio | -0.01 |
| Price/Sales Ratio | 518.32 |
| Price/Book Ratio | 1.01 |
| Enterprise/Revenue | 203.79 |
| Enterprise/EBITDA | -0.61 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -368.91 |
| Operating Margin | -381.59 |
AD
Management Effectiveness
| Return On Assets | -0.61 |
| Return On Equity | -0.81 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -8.44M |
| EBITDA | -82.16M |
| Net Income | -90.6M |
| Diluted EPS | -0.59 |
Balance Sheet
| Total Cash | 80.89M |
| Total Cash/Share | 0.53 |
| Total Debt | 10.12M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 5.75 |
| Book Value Per Share | 0.69 |
Price History
| 52-Week Change | 25.31 |
| 52-Week High | 2.35 |
| 52-Week Low | 0.53 |
| Moving Average 50 Days | 0.77 |
| Moving Average 200 Days | 1.01 |
Statistics
| Average Volume | 3.76M |
| Shares Outstanding | 166.6M |
| % Held by Institutions | 35.5 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
